Treace Medical Concepts, Inc.
TMCI
$6.45
-$0.07-1.07%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 96.74% | 27.57% | -13.55% | -197.34% | 64.15% |
| Total Depreciation and Amortization | -42.65% | 1.94% | 10.84% | 50.43% | -18.86% |
| Total Amortization of Deferred Charges | 1,352.70% | 0.00% | -1.33% | -86.93% | 665.33% |
| Total Other Non-Cash Items | 50.87% | -19.90% | 14.95% | 22.02% | 16.07% |
| Change in Net Operating Assets | -183.53% | -50.83% | -355.49% | 202.70% | -294.11% |
| Cash from Operations | 64.47% | 14.79% | -92.45% | -1,457.33% | 105.59% |
| Capital Expenditure | -7.37% | -65.59% | 55.97% | -74.69% | 35.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.70% | -64.30% | 214.40% | 5.93% | -10.41% |
| Cash from Investing | -40.64% | -74.31% | 496.94% | -24.95% | 8.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 612.50% | -97.43% | 498.08% | -70.79% | -97.68% |
| Repurchase of Common Stock | -- | -- | 100.00% | -1,723.08% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 225.00% | -97.43% | 268.11% | -212.12% | 3.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 87.48% | -168.62% | 342.52% | -163.96% | 219.91% |